Reuters (1/23, Rapaport) reports, “While only a minority of transgender youth who want puberty-blocking medicines receive this treatment,” research “suggests they may have a lower suicide risk when they get it.”
CNN (1/23, Christensen) reports investigators arrived at this conclusion after “analyzing data from the 2015 US Transgender Survey, involving 20,619 people between the ages of 18 and 36 years old.” The findings were published online Jan. 23 in Pediatrics. Currently, “at least six states are trying to restrict transgender kids from getting gender reassignment treatments.”
Providing similar coverage are Newsweek (1/23, Gander) and MedPage Today (1/23, Monaco).
Related Links:
— “For some trans youth, suicide risk lowers with puberty suppression, “Lisa Rapaport, Reuters, January 23, 2020